REGULATION OF FIBRIL ASSOCIATED COLLAGENS IN CORNEA
角膜中纤维相关胶原的调节
基本信息
- 批准号:2162664
- 负责人:
- 金额:$ 18.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-05-01 至 1996-04-30
- 项目状态:已结题
- 来源:
- 关键词:DNA binding protein DNA footprinting RNA splicing chick embryo collagen computer assisted sequence analysis cornea fibroblasts gene expression genetic library genetic manipulation genetic mapping genetic regulatory element genetic transcription in situ hybridization nucleic acid probes polymerase chain reaction reporter genes tissue /cell culture transcription factor transfection
项目摘要
Corneal transparency depends on the small uniform diameter and the
regular spacing of collagen fibrils. The "fibrillar" collagens are
involved in determining fibril diameter; the "fibril-associated"
collagens, a new class, may be responsible for interfibrillar
relationships, such as spacings. We have isolated cDNAs for two putative
"fibril associated" collagens expressed in cornea. One is for type XIV
collagen, a known member of a fibril-associated family; the other
potentially encodes a cornea-specific molecule with multiple, small
collagenous domains. The genes for these collagens will be characterized
and their exon/intron structures defined. Cis-acting elements (DNA
sequences) that are important for transcriptional regulation of the genes
will be identified. The region 5' to the transcriptional start site
(containing putative promoters/enhancers/silencers) will be examined, as
well as the first intron, which may .also be involved in transcriptional
regulation. These regions will be ligated to a reporter gene and the
constructs transfected into skin and corneal fibroblasts. To precisely
identify the regulatory sequences within these regions and to determine
whether the sequences function as promoters, enhancers, or silencers,
systematic nested deletions of portions of the regulatory regions of
these constructs will be made and evaluated by transfection. The
presence of potential cis-elements unique to cornea will be examined by
in vivo footprinting, a method which allows identification and sequencing
of regions of genes to which DNA-binding proteins (trans-acting factors)
are bound. The technique employs the polymerase chain reaction for
amplification, and thus can be performed on the amounts of tissues
available from embryos. Once obtained, the DNA sequences of these
cis-acting regions will be utilized to screen a corneal cDNA expression
library to isolate cDNAs expressing DNA binding proteins (trans-acting
factors). If trans-acting factors unique to cornea are found they will
be tested for functionality in co-transfection experiments. For this,
non-corneal cells, such as skin fibroblasts will be simultaneously
co-transfected with a construct encoding the transacting factor driven by
a constitutive promoter, and a construct of the promoter/enhancer regions
of the cornea-specific collagen gene promoter linked to a reporter gene.
If transcription of the reporter gene is observed, it will indicate that
a trans=acting factor unique to cornea is able to effect directly the
regulation of a cornea-specific gene in a non-corneal cell.
角膜透明度取决于较小的均匀直径和
胶原原纤维的规则间距。 “纤维状”胶原蛋白是
参与确定原纤维直径; “原纤维相关”
胶原蛋白是一类新的胶原蛋白,可能是导致纤维间纤维化的原因
关系,例如间距。 我们已经分离出两个假定的 cDNA
在角膜中表达的“原纤维相关”胶原蛋白。 一种适用于 XIV 型
胶原蛋白,原纤维相关家族的已知成员;另一个
可能编码具有多个小分子的角膜特异性分子
胶原域。 这些胶原蛋白的基因将被表征
及其外显子/内含子结构的定义。 顺式作用元件(DNA
对基因转录调控很重要的序列)
将被识别。 转录起始位点 5' 区域
(包含假定的启动子/增强子/沉默子)将被检查,因为
以及第一个内含子,也可能参与转录
规定。 这些区域将连接到报告基因和
转染到皮肤和角膜成纤维细胞中的构建体。 准确地说
鉴定这些区域内的调控序列并确定
序列是否充当启动子、增强子或沉默子,
部分调控区域的系统性嵌套删除
这些构建体将通过转染来制备和评估。 这
角膜特有的潜在顺式元素的存在将通过以下方式进行检查
体内足迹法,一种允许识别和测序的方法
DNA 结合蛋白(反式作用因子)所结合的基因区域
被绑定。 该技术采用聚合酶链式反应
放大,因此可以对组织的数量进行
可以从胚胎中获得。 一旦获得这些DNA序列
顺式作用区将用于筛选角膜 cDNA 表达
用于分离表达 DNA 结合蛋白(反式作用
因素)。 如果发现角膜特有的反式作用因子,他们将
在共转染实验中测试其功能。 为了这,
非角膜细胞,例如皮肤成纤维细胞将同时
与编码驱动因子的构建体共转染
组成型启动子和启动子/增强子区域的构建体
与报告基因连接的角膜特异性胶原蛋白基因启动子。
如果观察到报告基因的转录,则表明
角膜独有的反式作用因子能够直接影响
非角膜细胞中角膜特异性基因的调节。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARION K GORDON其他文献
MARION K GORDON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARION K GORDON', 18)}}的其他基金
Transmembraneous collagens and matrix metalloproteinases as targets for counterme
跨膜胶原蛋白和基质金属蛋白酶作为对抗靶标
- 批准号:
7933776 - 财政年份:2009
- 资助金额:
$ 18.1万 - 项目类别:
Transmembraneous collagens and matrix metalloproteinases as targets for counterme
跨膜胶原蛋白和基质金属蛋白酶作为对抗靶标
- 批准号:
7653731 - 财政年份:2008
- 资助金额:
$ 18.1万 - 项目类别:
Transmembraneous collagens and matrix metalloproteinases as targets for counterme
跨膜胶原蛋白和基质金属蛋白酶作为对抗靶点
- 批准号:
7468060 - 财政年份:2007
- 资助金额:
$ 18.1万 - 项目类别:
Transmembraneous collagens and matrix metalloproteinases as targets for counterme
跨膜胶原蛋白和基质金属蛋白酶作为对抗靶点
- 批准号:
8743070 - 财政年份:2006
- 资助金额:
$ 18.1万 - 项目类别:
Research Project II - Vesicant-Induced Corneal Injury
研究项目 II - 起泡剂引起的角膜损伤
- 批准号:
10291227 - 财政年份:2006
- 资助金额:
$ 18.1万 - 项目类别:
Transmembraneous collagens and matrix metalloproteinases as targets for counterme
跨膜胶原蛋白和基质金属蛋白酶作为对抗靶点
- 批准号:
8210200 - 财政年份:2006
- 资助金额:
$ 18.1万 - 项目类别:
Transmembraneous collagens and matrix metalloproteinases as targets for counterme
跨膜胶原蛋白和基质金属蛋白酶作为对抗靶点
- 批准号:
8545530 - 财政年份:2006
- 资助金额:
$ 18.1万 - 项目类别:
Transmembraneous collagens and matrix metalloproteinases as targets for counterme
跨膜胶原蛋白和基质金属蛋白酶作为对抗靶点
- 批准号:
8932579 - 财政年份:2006
- 资助金额:
$ 18.1万 - 项目类别:
Transmembraneous collagens and matrix metalloproteinases as targets for counterme
跨膜胶原蛋白和基质金属蛋白酶作为对抗靶标
- 批准号:
7235218 - 财政年份:2006
- 资助金额:
$ 18.1万 - 项目类别:
Transmembraneous collagens and matrix metalloproteinases as targets for counterme
跨膜胶原蛋白和基质金属蛋白酶作为对抗靶点
- 批准号:
8382002 - 财政年份:2006
- 资助金额:
$ 18.1万 - 项目类别:
相似国自然基金
天蓝色链霉菌中DNA甲基化依赖型限制系统的发现与表征
- 批准号:31170083
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
MECHANISM OF ELAV DEPENDENT NEURAL SPECIFIC SPLICING
ELAV 依赖性神经特异性剪接机制
- 批准号:
2420650 - 财政年份:1998
- 资助金额:
$ 18.1万 - 项目类别: